Revive Therapeutics Ltd. (RVV.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.4 Million CAD | -5.42% |
| 2022 | 3.59 Million CAD | -19.35% |
| 2021 | 4.46 Million CAD | 346.4% |
| 2020 | 999.67 Thousand CAD | 20.22% |
| 2019 | 831.55 Thousand CAD | 158.43% |
| 2018 | 321.77 Thousand CAD | 7.51% |
| 2017 | 299.3 Thousand CAD | -2.98% |
| 2016 | 308.5 Thousand CAD | -62.31% |
| 2015 | 818.43 Thousand CAD | 168.83% |
| 2014 | 304.43 Thousand CAD | 291.43% |
| 2013 | 77.77 Thousand CAD | 664.91% |
| 2012 | 10.16 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 3.34 Million CAD | -4.9% |
| 2023 Q4 | 3.4 Million CAD | 2.36% |
| 2023 Q1 | 3.51 Million CAD | -2.24% |
| 2023 Q3 | 3.32 Million CAD | -0.62% |
| 2022 Q2 | 4.33 Million CAD | 16.27% |
| 2022 Q3 | 3.92 Million CAD | -9.48% |
| 2022 FY | 3.59 Million CAD | -19.35% |
| 2022 Q4 | 3.59 Million CAD | -8.2% |
| 2022 Q1 | 3.72 Million CAD | -16.52% |
| 2021 Q4 | 4.46 Million CAD | 33.86% |
| 2021 FY | 4.46 Million CAD | 346.4% |
| 2021 Q1 | 3.87 Million CAD | 287.22% |
| 2021 Q2 | 1.41 Million CAD | -63.47% |
| 2021 Q3 | 3.33 Million CAD | 135.74% |
| 2020 Q2 | 889.49 Thousand CAD | 24.76% |
| 2020 Q3 | 1.01 Million CAD | 13.67% |
| 2020 Q4 | 999.67 Thousand CAD | -1.13% |
| 2020 FY | 999.67 Thousand CAD | 20.22% |
| 2020 Q1 | 712.97 Thousand CAD | -14.26% |
| 2019 Q1 | 882.15 Thousand CAD | 174.16% |
| 2019 Q4 | 831.55 Thousand CAD | -38.52% |
| 2019 Q3 | 1.35 Million CAD | 75.46% |
| 2019 FY | 831.55 Thousand CAD | 158.43% |
| 2019 Q2 | 770.89 Thousand CAD | -12.61% |
| 2018 Q3 | 262.02 Thousand CAD | -4.12% |
| 2018 Q1 | 269.85 Thousand CAD | -9.84% |
| 2018 FY | 321.77 Thousand CAD | 7.51% |
| 2018 Q4 | 321.77 Thousand CAD | 22.8% |
| 2018 Q2 | 273.28 Thousand CAD | 1.27% |
| 2017 Q2 | 293.4 Thousand CAD | -18.58% |
| 2017 FY | 299.3 Thousand CAD | -2.98% |
| 2017 Q3 | 311.86 Thousand CAD | 6.29% |
| 2017 Q4 | 299.3 Thousand CAD | -4.03% |
| 2017 Q1 | 360.34 Thousand CAD | 16.81% |
| 2016 FY | 308.5 Thousand CAD | -62.31% |
| 2016 Q3 | 277.13 Thousand CAD | -31.99% |
| 2016 Q4 | 308.5 Thousand CAD | 11.32% |
| 2016 Q2 | 407.51 Thousand CAD | -33.18% |
| 2016 Q1 | 609.86 Thousand CAD | -25.48% |
| 2015 Q1 | 450.63 Thousand CAD | 48.02% |
| 2015 Q4 | 818.43 Thousand CAD | 25.8% |
| 2015 FY | 818.43 Thousand CAD | 168.83% |
| 2015 Q3 | 650.59 Thousand CAD | 46.64% |
| 2015 Q2 | 443.67 Thousand CAD | -1.55% |
| 2014 Q4 | 304.43 Thousand CAD | 62.62% |
| 2014 Q2 | 125.4 Thousand CAD | -13.63% |
| 2014 Q1 | 145.2 Thousand CAD | 86.7% |
| 2014 Q3 | 187.21 Thousand CAD | 49.28% |
| 2014 FY | 304.43 Thousand CAD | 291.43% |
| 2013 Q4 | 77.77 Thousand CAD | 115.46% |
| 2013 FY | 77.77 Thousand CAD | 664.91% |
| 2013 Q2 | 210.06 Thousand CAD | 1265.92% |
| 2013 Q3 | 36.09 Thousand CAD | -82.82% |
| 2013 Q1 | 15.37 Thousand CAD | -43.77% |
| 2012 FY | 10.16 Thousand CAD | 0.0% |
| 2012 Q4 | 27.35 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | -15.918% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | 76.228% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -623.129% |
| The BC Bud Corporation | 626 Thousand CAD | -443.756% |
| BioNxt Solutions Inc. | 6.55 Million CAD | 48.033% |
| CordovaCann Corp. | 11.29 Million CAD | 69.852% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | 59.958% |
| Captor Capital Corp. | 28.76 Million CAD | 88.166% |
| City View Green Holdings Inc. | 3.73 Million CAD | 8.814% |
| 1CM Inc. | 9.42 Million CAD | 63.879% |
| Global Hemp Group Inc. | 5.82 Million CAD | 41.565% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 83.924% |
| IM Cannabis Corp. | 35.11 Million CAD | 90.306% |
| Lobe Sciences Ltd. | 2.45 Million CAD | -38.393% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | 66.234% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -1219.354% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | 22.697% |
| Ovation Science Inc. | 728.99 Thousand CAD | -366.937% |
| Pharmadrug Inc. | 2.92 Million CAD | -16.355% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | -62.949% |
| RAMM Pharma Corp. | 2.83 Million CAD | -20.047% |
| RIV Capital Inc. | 275.63 Million CAD | 98.765% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 99.066% |
| SLANG Worldwide Inc. | 37.58 Million CAD | 90.943% |
| 1933 Industries Inc. | 23.28 Million CAD | 85.38% |
| Red Light Holland Corp. | 3.82 Million CAD | 10.93% |
| Top Strike Resources Corp. | 20.99 Million CAD | 83.786% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | -330.902% |
| Adastra Holdings Ltd. | 17.65 Million CAD | 80.723% |